These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

237 related items for PubMed ID: 12414849

  • 1. The effect of micronized estradiol on bone turnover and calciotropic hormones in older men receiving hormonal suppression therapy for prostate cancer.
    Taxel P, Fall PM, Albertsen PC, Dowsett RD, Trahiotis M, Zimmerman J, Ohannessian C, Raisz LG.
    J Clin Endocrinol Metab; 2002 Nov; 87(11):4907-13. PubMed ID: 12414849
    [Abstract] [Full Text] [Related]

  • 2. Effects of selective testosterone and estradiol withdrawal on skeletal sensitivity to parathyroid hormone in men.
    Lee H, Finkelstein JS, Miller M, Comeaux SJ, Cohen RI, Leder BZ.
    J Clin Endocrinol Metab; 2006 Mar; 91(3):1069-75. PubMed ID: 16352679
    [Abstract] [Full Text] [Related]

  • 3. Effects of gonadal steroid suppression on skeletal sensitivity to parathyroid hormone in men.
    Leder BZ, Smith MR, Fallon MA, Lee ML, Finkelstein JS.
    J Clin Endocrinol Metab; 2001 Feb; 86(2):511-6. PubMed ID: 11158001
    [Abstract] [Full Text] [Related]

  • 4. The effect of short-term treatment with micronized estradiol on bone turnover and gonadotrophins in older men.
    Taxel P, Kennedy D, Fall P, Willard A, Shoukri K, Clive J, Raisz LG.
    Endocr Res; 2000 Aug; 26(3):381-98. PubMed ID: 11019903
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effects of intranasal 17beta-estradiol on bone turnover and serum insulin-like growth factor I in postmenopausal women.
    Garnero P, Tsouderos Y, Marton I, Pelissier C, Varin C, Delmas PD.
    J Clin Endocrinol Metab; 1999 Jul; 84(7):2390-7. PubMed ID: 10404809
    [Abstract] [Full Text] [Related]

  • 9. Effect of micronized progesterone on bone turnover in postmenopausal women on estrogen replacement therapy.
    Azizi G, Hansen A, Prestwood KM.
    Endocr Res; 2003 May; 29(2):133-40. PubMed ID: 12856800
    [Abstract] [Full Text] [Related]

  • 10. Alendronate does not block the anabolic effect of PTH in postmenopausal osteoporotic women.
    Cosman F, Nieves J, Woelfert L, Shen V, Lindsay R.
    J Bone Miner Res; 1998 Jun; 13(6):1051-5. PubMed ID: 9626638
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effect of discontinuation of estrogen, calcitriol, and the combination of both on bone density and bone markers.
    Gallagher JC, Rapuri PB, Haynatzki G, Detter JR.
    J Clin Endocrinol Metab; 2002 Nov; 87(11):4914-23. PubMed ID: 12414850
    [Abstract] [Full Text] [Related]

  • 13. Effect of alendronate and MK-677 (a growth hormone secretagogue), individually and in combination, on markers of bone turnover and bone mineral density in postmenopausal osteoporotic women.
    Murphy MG, Weiss S, McClung M, Schnitzer T, Cerchio K, Connor J, Krupa D, Gertz BJ, MK-677/Alendronate Study Group.
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1116-25. PubMed ID: 11238495
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Raloxifene treatment is associated with increased serum estradiol and decreased bone remodeling in healthy middle-aged men with low sex hormone levels.
    Uebelhart B, Herrmann F, Pavo I, Draper MW, Rizzoli R.
    J Bone Miner Res; 2004 Sep; 19(9):1518-24. PubMed ID: 15312253
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Daily oral magnesium supplementation suppresses bone turnover in young adult males.
    Dimai HP, Porta S, Wirnsberger G, Lindschinger M, Pamperl I, Dobnig H, Wilders-Truschnig M, Lau KH.
    J Clin Endocrinol Metab; 1998 Aug; 83(8):2742-8. PubMed ID: 9709941
    [Abstract] [Full Text] [Related]

  • 19. Effects of raloxifene, a selective estrogen receptor modulator, on bone turnover markers and serum sex steroid and lipid levels in elderly men.
    Doran PM, Riggs BL, Atkinson EJ, Khosla S.
    J Bone Miner Res; 2001 Nov; 16(11):2118-25. PubMed ID: 11697809
    [Abstract] [Full Text] [Related]

  • 20. High serum IGFBP-2 is predictive of increased bone turnover in aging men and women.
    Amin S, Riggs BL, Melton LJ, Achenbach SJ, Atkinson EJ, Khosla S.
    J Bone Miner Res; 2007 Jun; 22(6):799-807. PubMed ID: 17352648
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.